311 related articles for article (PubMed ID: 10087662)
1. Host response and vaccine development to Helicobacter pylori infection.
Blanchard TG; Czinn SJ; Nedrud JG
Curr Top Microbiol Immunol; 1999; 241():181-213. PubMed ID: 10087662
[TBL] [Abstract][Full Text] [Related]
2. Host Nonresponsiveness Does not Interfere With Vaccine-Mediated Protection Against Gastric Helicobacter Infection.
Harbour SN; Mitchell HM; Sutton P
Helicobacter; 2015 Jun; 20(3):217-22. PubMed ID: 25683672
[TBL] [Abstract][Full Text] [Related]
3. T-cell-mediated mucosal immunity in the absence of antibody: lessons from Helicobacter pylori infection.
Ernst PB; Pappo J
Acta Odontol Scand; 2001 Aug; 59(4):216-21. PubMed ID: 11570524
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
5. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
6. Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
Liu W; Tan Z; Liu H; Zeng Z; Luo S; Yang H; Zheng L; Xi T; Xing Y
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28805287
[TBL] [Abstract][Full Text] [Related]
7. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model.
Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y
Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531
[TBL] [Abstract][Full Text] [Related]
8. Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles.
Kim SY; Doh HJ; Jang MH; Ha YJ; Chung SI; Park HJ
Helicobacter; 1999 Mar; 4(1):33-9. PubMed ID: 10352085
[TBL] [Abstract][Full Text] [Related]
9. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model.
Sawai N; Kita M; Kodama T; Tanahashi T; Yamaoka Y; Tagawa Y; Iwakura Y; Imanishi J
Infect Immun; 1999 Jan; 67(1):279-85. PubMed ID: 9864227
[TBL] [Abstract][Full Text] [Related]
10. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
[TBL] [Abstract][Full Text] [Related]
11. Preventive and therapeutic vaccines against Helicobacter pylori: current status and future challenges.
Ernst PB; Pappo J
Curr Pharm Des; 2000 Oct; 6(15):1557-73. PubMed ID: 10974152
[TBL] [Abstract][Full Text] [Related]
12. Inflammation, Immunity, and Vaccine Development for the Gastric Pathogen Helicobacter pylori.
Ikuse T; Blanchard TG; Czinn SJ
Curr Top Microbiol Immunol; 2019; 421():1-19. PubMed ID: 31123883
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection.
Ikewaki J; Nishizono A; Goto T; Fujioka T; Mifune K
Microbiol Immunol; 2000; 44(1):29-39. PubMed ID: 10711597
[TBL] [Abstract][Full Text] [Related]
14. Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice.
Blanchard TG; Czinn SJ; Redline RW; Sigmund N; Harriman G; Nedrud JG
Cell Immunol; 1999 Jan; 191(1):74-80. PubMed ID: 9918689
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
16. A vaccine against Helicobacter pylori: towards understanding the mechanism of protection.
Aebischer T; Walduck A; Schroeder J; Wehrens A; Chijioke O; Schreiber S; Meyer TF
Int J Med Microbiol; 2008 Jan; 298(1-2):161-8. PubMed ID: 17702653
[TBL] [Abstract][Full Text] [Related]
17. Importance of the host genetic background on immune responses to Helicobacter pylori infection and therapeutic vaccine efficacy.
Kim JS; Chang JH; Chung SI; Yum JS
FEMS Immunol Med Microbiol; 2001 Jul; 31(1):41-6. PubMed ID: 11476980
[TBL] [Abstract][Full Text] [Related]
18. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
19. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.
Lee CK; Weltzin R; Thomas WD; Kleanthous H; Ermak TH; Soman G; Hill JE; Ackerman SK; Monath TP
J Infect Dis; 1995 Jul; 172(1):161-72. PubMed ID: 7797906
[TBL] [Abstract][Full Text] [Related]
20. Inflammation, Immunity, and Vaccines for Helicobacter pylori Infection.
Walduck A; Andersen LP; Raghavan S
Helicobacter; 2015 Sep; 20 Suppl 1():17-25. PubMed ID: 26372820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
